8 results

  • bupropion hydrochloride

    (bupropion hydrochloride)
    ScieGen Pharmaceuticals, Inc.
    Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) in adults. Its efficacy has been established in both inpatient and outpatient trials, demonstrating effectiveness in acute treatment and maintaining an antidepressant response for up to 44 weeks.

  • celecoxib

    (Celecoxib)
    ScieGen Pharmaceuticals, Inc.
    Celecoxib is indicated for managing the signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

  • enalapril maleate

    (ENALAPRIL MALEATE)
    ScieGen Pharmaceuticals, Inc.
    Enalapril maleate tablets are indicated for treating hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction. They enhance blood pressure control, improve heart failure symptoms, and reduce hospitalization rates. Effectiveness may vary among different ethnic groups, with a noted higher incidence of angioedema in black patients.

  • fluoxetine

    (Fluoxetine Hydrochloride)
    ScieGen Pharmaceuticals, Inc.
    Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, binge-eating and vomiting behaviors in Bulimia Nervosa, and Panic Disorder. It is also indicated in combination with Olanzapine for treating depressive episodes in Bipolar I Disorder and treatment-resistant depression.

  • irbesartan

    (Irbesartan)
    ScieGen Pharmaceuticals, Inc.
    Irbesartan is indicated for treating hypertension to lower blood pressure, thereby reducing the risk of cardiovascular events. It is also used for managing nephropathy in type 2 diabetic patients with hypertension, elevated serum creatinine, and proteinuria, slowing kidney disease progression.

  • naproxen

    (Naproxen)
    ScieGen Pharmaceuticals, Inc.
    Naproxen Tablets are indicated for the relief of symptoms associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendonitis, bursitis, and acute gout, as well as for managing pain and primary dysmenorrhea.

  • omeprazole and sodium bicarbonate

    (Omeprazole and Sodium Bicarbonate)
    ScieGen Pharmaceuticals, Inc.
    Omeprazole and sodium bicarbonate capsules are indicated for adults to treat active duodenal and benign gastric ulcers, heartburn and GERD symptoms, and erosive esophagitis (EE) due to GERD. It supports healing maintenance of EE, with treatment durations typically ranging from 4 to 8 weeks, not exceeding 12 months for maintenance.

  • solifenacin succinate

    (SOLIFENACIN SUCCINATE)
    ScieGen Pharmaceuticals, Inc.
    Solifenacin succinate is indicated for treating adults with overactive bladder, specifically addressing symptoms of urge urinary incontinence, urgency, and urinary frequency.